2024 Technology & Life Sciences Benchmark Report

This report presents an analysis of the second annual study of the customers in the Assurex Partners’ technology and life sciences client base. The report examines the insurance purchasing decisions of 284 businesses, which generate an aggregate $3.6 billion in sales.

The life sciences market segment is also growing rapidly. Overall, the life sciences industry in 2023 is navigating a complex landscape of innovation, regulatory changes and market dynamics, with a strong focus on R&D, digital transformation, and strategic planning for future challenges and opportunities.

The insurance purchasing decision is often made in the absence of good information that would allow a buyer to compare their decision with appropriate benchmarks. Request the full report to gain insight into a framework that can help optimize your own purchasing decisions. An RCM&D representative can provide additional information and guidance to help you achieve your risk management objectives.